
News|Articles|January 3, 2024
Get Ready, Pharma: How Point-Of-Care AI Could Transform Commercial Strategy While Improving Patient Outcomes
Author(s)Viz.ai
Pharma leaders are increasingly allocating budget toward real-time clinical alerts that integrate with and improve patient care. By investing in algorithms that auto-detect diseases as common as heart failure and as rare as pulmonary arterial hypertension, manufacturers can help accelerate time to diagnosis and treatment, streamline monitoring and identify new patients while starting them on the right therapies faster.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
5
